Shandong Bailong Chuangyuan Bio-Tech (605016.SH)'s application to issue convertible bonds has received approval for registration from the CSRC.
Bailong Chuangyuan (605016.SH) announced that the company recently received the "Approval Regarding the Registration of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s Issuance of Convertible Corporate Bonds to Unspecific Objects" (CSRC Permit [2026] No. 2701) issued by the China Securities Regulatory Commission, approving the company's registration application for the issuance of convertible corporate bonds to unspecific objects.
Shandong Bailong Chuangyuan Bio-Tech (605016.SH) announced that the company recently received the "Approval Regarding the Registration of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s Issuance of Convertible Corporate Bonds to Unspecific Targets" (CSRC Permit [2026] No. 2701) issued by the China Securities Regulatory Commission, approving the company's registration application for the issuance of convertible corporate bonds to unspecific targets.
Related Articles
ESPRIT HOLDINGS (00330): Liu Jianyi Resigns as Non-Executive Director
SUN.KING TECH (00580) repurchased 150,000 shares for approximately HK$158,200 on October 12.
ASCLETIS-B (01672) repurchased 200,000 shares for approximately HK$1.3703 million on October 12.
ESPRIT HOLDINGS (00330): Liu Jianyi Resigns as Non-Executive Director
SUN.KING TECH (00580) repurchased 150,000 shares for approximately HK$158,200 on October 12.
ASCLETIS-B (01672) repurchased 200,000 shares for approximately HK$1.3703 million on October 12.
